1 American Diabetes Association Standards of medical care in diabetes (2011) Diabetes Care, 34: S11–S61.
2 Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guide- line.
Diabetes Res Clin Pract 2014; 103:341–63; National Institute for Health and Clinical Excellence. Putting NICE guidance into practice. Accessed 2015 Feb)
3 WHO Regional Office for Europe (2018) Health for All Explorer - European Health Information Gateway.
4 Janssen F, Bardoutsos A, Vidra N (2020) Obesity Prevalence in the Long-Term Future in 18 European Countries and in the
USA. Obes Facts, 13: 514-27.
5 Lutsiv O, Mah J, Beyene J, Mcdonald SD (2015) The Effects of Morbid Obesity on Maternal and Neonatal Health Outcomes: A
Systematic Review and Meta-Analyses. Obes Rev, 16: 531-46.
6 HAPO Study Cooperative research Group (2009) Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations
with neonatal anthropometrics. Diabetes, 58: 453–9.
7 Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, et al. (2011) Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab, 14: 612-22.
8Moon DO (2023) A comprehensive review of the effects of resveratrol on glucose metabolism: unveiling the molecular pathways
and therapeutic potential in diabetes management. Mol Biol Rep, 50: 8743-55.
9 Ma HZ, Chen Y, Guo HH, Wang J, Xin XL et al. (2023) Effect of resveratrol in gestational diabetes mellitus and its complications. World J Diabetes, 14: 808-19.
10 Diniz MS, Magalhães CC, Tocantins C, Grilo LF, Teixeira J et al. (2023) Nurturing through Nutrition: Exploring the Role of
Antioxidants in Maternal Diet during Pregnancy to Mitigate Developmental Programming of Chronic Diseases. Nutrients, 15:
4623.
11 Guschlbauer M, Klinger S, Burmester M, Horn J, Kulling SE et al. (2013) Trans-resveratrol and ε-viniferin decrease glucose absorption in porcine jejunum and ileum in vitro. Comp Biochem Physiol A Mol Integr Physiol, 165: 313–8.
12 Luo G, Xiao L, Wang D, Wang N, Luo C et al. (2020) Resveratrol protects against ethanol-induced impairment of insulin secretion in INS-1 cells through SIRT1-UCP2 axis. Toxicol In Vitro, 65: 104808.
13 Rouse M, Younès A, Egan JM (2014) Resveratrol and curcumin enhance pancreatic β-cell function by inhibiting phosphodiesterase activity. J Endocrinol, 223: 107–117.
14Huang Y, Zhu X, Chen K, Lang H, Zhang Y et al. (2019) Resveratrol prevents sarcopenic obesity by reversing mitochondrial
dysfunction and oxidative stress via the PKA/LKB1/AMPK pathway. Aging, 11: 2217-40.
15 Holloway RW, Marignani PA (2021) Targeting mTOR and glycolysis in HER2-Positive breast Cancer. Cancers (Basel), 13:
2922.
16 Konrad D, Somwar R, Sweeney G, Yaworsky K, Hayashi M et al. (2001) The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 Translocation and GLUT4 Activation. Diabetes, 50: 1464-71.
17 Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2002) Oxidative stress and stress-activated signaling pathways: a unifying
hypothesis of type 2 diabetes. Endocr Rev, 23: 599-622.
18 Kahn BB, Alquier T, Carling D, Hardie DG (2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab, 1: 15-25.
19 Richter EA, Derave W, Wojtaszewski JF (2001) Glucose, exercise and insulin: emerging concepts. J Physiol, 535: 313-22.
20 Aslfalah H, Jamilian M, Ansarihadipour H, Abdollahi M, Khosrowbeygi A (2020) Effect of alpha-lipoic acid supplementation
on the lipid profile and lipid ratios in women with gestational diabetes mellitus: A clinical trial study. Int J Reprod Biomed,
18:1029-38.
21 Aslfalah H, Jamilian M, Rafiei F, Khosrowbeygi A (2019) Reduction in maternal serum values of glucose and gamma- glutamyltransferase after supplementation with alpha-lipoic acid in women with gestational diabetes mellitus. J Obstet Gynaecol Res, 45:
313-7.
22 Mandani M, Badehnoosh B, Jalali-Mashayekhi F, Tavakoli-Far B, Khosrowbeygi A (2021) Alpha-lipoic acid supplementation
effects on serum values of some oxidative stress biomarkers in women with gestational diabetes. Gynecol Endocrinol, 37: 1111-5.
23 Zhang G, Wang X, Ren B, Zhao Q, Zhang F (2021) The Effect of Resveratrol on Blood Glucose and Blood Lipids in Rats with
Gestational Diabetes Mellitus. Evid Based Complement Alternat Med, 2956795.
24 Wu X, Xiao B (2023) TDAG51 Attenuates Impaired Lipid Metabolism and Insulin Resistance in Gestational Diabetes Mellitus
Through SREBP-1/ANGPTL8 Pathway. Balkan Med J, 40: 175-81.
25 Singh G, Pai RS (2015) Trans-resveratrol self-nano-emulsifying drug delivery system (SNEDDS) with enhanced bioavailability
potential: optimization, pharmacokinetics and in situ single pass intestinal perfusion (SPIP) studies. Drug Deliv, 22: 522-30.
26 Sergides C, Chirila M, Silvestro L, Pitta D, Pittas A (2016) Bioavailability and safety study of resveratrol 500 mg tablets in
healthy male and female volunteers. Exp Ther Med, 11: 164-70.
27Iannitti RG, Floridi A, Lazzarini A, Tantucci A, Russo R et al. (2020) Resveratrol Supported on Magnesium DiHydroxide
(Resv@MDH) Represents an Oral Formulation of Resveratrol With Better Gastric Absorption and Bioavailability Respect to Pure
Resveratrol. Front Nutr, 7: 570047
28 Curry AM, White DS, Donu D, Cen Y (2021) Human Sirtuin Regulators: The "Success" Stories. Front Physiol, 12: 752117
29 Spogli R, Bastianini M, Ragonese F, Iannitti RG, Monarca L et al. (2018) Solid Dispersion of Resveratrol Supported on Magnesium DiHydroxide (Resv@MDH) Microparticles Improves Oral Bioavailability. Nutrients, 10: 1925.
30 Malvasi A, Kosmas I, Mynbaev OA, Sparic R, Gustapane S et al. (2017) Can trans resveratrol plus d-chiro-inositol and myo-inositol improve maternal metabolic profile in overweight pregnant patients? Clin Ter, 168: e240-7.
31 Panico A, Lupoli GA, Lupoli R, Romano F, Barba L et al. (2017) Resveratrol improves the lipid profile promoted by red yeast
rice (monacolin k) in patients with moderate dyslipidemia: An open-label, randomized, parallel-group controlled clinical trial. Eurobiotech J, 1: 72-5.
32 Gerli S, Della Morte C, Ceccobelli M, Mariani M, Favilli A et al. (2022) Biological and clinical effects of a resveratrol- based
multivitamin supplement on intracytoplasmic sperm injection cycles: a single-center, randomized controlled trial. J Matern Fetal Neonatal Med, 35: 7640-8.
33 Illiano E, Trama F, Zucchi A, Iannitti RG, Fioretti B et al. (2020) Resveratrol-Based Multivitamin Supplement Increases Sperm
Concentration and Motility in Idiopathic Male Infertility: A Pilot Clinical Study. J Clin Med, 9: 4017.
34 De-Regil LM, Palacios C, Lombardo LK, Peña-Rosas JP (2016) Vitamin D supplementation for women during pregnancy.
Cochrane Database Syst Rev, 14: CD008873.
35 Mussai EX, Lofft ZA, Vanderkruk B, Boonpattrawong N, Miller JW et al. (2023) Folic acid supplementation in a mouse model
of diabetes in pregnancy alters insulin sensitivity in female mice and beta cell mass in offspring. FASEB J, 37: e23200.
36Ren Q, Wang H, Zeng Y, Tan X, Cheng X et al. (2023) The Association Between Serum Magnesium Levels and Gestational Diabetes Mellitus: a Systematic Review and Meta-Analysis. Biol Trace Elem Res, 201: 5115-25.
37 Cao X, Wu M, Zhang G, Lin L, Tu M et al. (2023) Longitudinal plasma magnesium status during pregnancy and the risk of gestational diabetes mellitus: a prospective cohort study. Environ Sci Pollut Res Int, 30: 65392-400.
38 Di Cianni G, Lacaria E, Lencioni C, Resi V (2018) Preventing type 2 diabetes and cardiovascular disease in women with gestational diabetes - The evidence and potential strategies. Diabetes Res Clin Pract, 145: 184-92.
39 Borra MT, Smith BC, Denu JM (2005) Mechanism of human SIRT1 activation by resveratrol. J Biol Chem, 280: 17187-95.
40 Chen WL, Kang CH, Wang SG, Lee HM (2012) α-Lipoic acid regulates lipid metabolism through induction of sirtuin 1
(SIRT1) and activation of AMP-activated protein kinase. Diabetologia 55: 1824-35.
41 Kıraç FS (2013) Is Ethics Approval Necessary for all Trials? A Clear but Not Certain Process. Mol Imaging Radionucl Ther,
22:73-5.